Company intelligence / Profile preview

Samplix

Birkerød, Capital Region of Denmark, Denmarksamplix.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Samplix provides commercial-stage microfluidic droplet-based platforms for high-resolution single-cell and molecular analyses. Their Xdrop® system enables PCR-free target enrichment of DNA/RNA from complex samples at single-molecule resolution. The technology supports applications including gene therapy validation, detection of off-target genome editing events, rare variant discovery in genomics studies, enzyme engineering screens, immunotherapy cell function assays (e.g., CAR-T), among others. The products are used by academic labs as well as biopharma R&D groups worldwide. No clinical results—products are for research use only.

Therapeutic areas
OtherRare DiseasesNeurology
Modalities
DeviceMicrofluidics technology platform (enabling single-cell and molecular analysis)PCR-free target enrichment technology
Industry
Non-Drug Biotech
02

Partnerships

Collaborates with academic researchers and pharmaceutical companies on assay development/use cases; no major named pharma partnerships disclosed publicly.

Beyond the preview

Go deeper on Samplix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Samplix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call